# the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

> **NCT03264794** · PHASE4 · UNKNOWN · sponsor: **Jiangsu Famous Medical Technology Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Gefitinib Tab （CTTQ），First medication；Gefitinib Tab （CTTQ），From the 8th day of trial
- **DRUG:** Gefitinib tablets (Yi Ruisha），First medication
- **DRUG:** Gefitinib Tab 250 MG（CTTQ），From the 8th day of trial.

## Key facts

- **NCT ID:** NCT03264794
- **Lead sponsor:** Jiangsu Famous Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08
- **Primary completion:** 2021-12
- **Final completion:** 2022-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264794, "the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03264794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*